Clinical Research FAQs at Mountain View Headache and Spine Institute in Phoenix, and Sun City, AZ
Visit Mountain View Headache and Spine Institute today to get specialized and expert care. For more information, please contact us today or book an appointment online. We have convenient locations to serve you in Phoenix AZ and Sun City AZ.
Table of Contents:
Where is Mountain View Headache and Spine located?
What hours are you open?
What is the process for new patients?
Do I need a referral?
What insurance do you take?
How much do you charge for IV ketamine infusions?
How much do you charge for IV vitamin infusions?
Are bone marrow concentrate therapy covered by insurance?
Are bone marrow concentrate products approved by the FDA?
We are located at 2222 E. Highland Ave, Suite 110, Phoenix. We are between Exit 5 and 4b on Highway 51. There is ample parking in the parking lot and because we are on the main floor, there is no need to use stairs or elevators.
We are open M-F 8 am to 4 pm and after hours and weekends by appointment.
To make an appointment simply submit the contact form on the website or call 602-767-0007. Once the appointment is made, we will send you an intake form. We prefer new patients fill out our intake form and submit it before their appointment. If you do not have the resources to fill it out online, our office can print it out for you, mail or email it to you. Once the intake form is received, the doctor will review the paperwork, along with any prior medical records and/or imaging that is obtained. This will make your appointment date much smoother.
Depending on your insurance you may need a referral. However, the best approach is to contact us and we will work with you to obtain this referral.
We work with all insurances.
Most of our ketamine infusions are covered by insurance. For those who are self-pay, we offer a financing option through Advanced Credit, whereby patients receive 14 months of no-interest financing.
Like ketamine, most of our vitamin infusions are covered by insurance. For those who are self pay, we offer a financing option through Advanced Credit, whereby patients receive 14 months of no-interest financing.
These procedures are not routinely covered by insurance at this time. However, our supplier, Regenexx, is the only bone marrow concentrate orthopedic product in America that has insurance coverage through some self-funded employers. If you would like to find out if your employer currently covers Regenexx, complete this form and we will respond to you as soon as possible.
Additionally, health insurance plans may cover the initial evaluation. If your plan does, and we are part of your insurance carrier network, we will bill the carrier. If not, there will be a consultation fee for the initial face-to-face consult.
We recommend that you contact your insurance carrier for more information about your specific coverage details
Regenexx procedures are exempt from FDA regulation.
Each of the Regenexx procedures available in the United States involves the patient’s own bone marrow or blood, and the Regenexx network of doctors only treats musculoskeletal conditions. Further, none of the Regenexx procedures available in the United States involves the culture expansion of the patient’s cells to create a larger number of cells. Thus, the Regenexx procedures available in the United States generally fall into the following regulatory exemptions:
• For our procedures involving concentrated bone marrow, minimally manipulated bone marrow for homologous use is not subject to FDA regulation as a human cell, tissue, or cellular or tissue-based product (HCT/P); 21 CFR 1271.3(d).
• For our procedures involving autologous blood (such as Super Concentrated Plasma), practitioners who are licensed by law to prescribe or administer drugs and who manufacture blood products solely for use in the course of their professional practice are not subject to FDA regulation; 21 CFR 607.65.
• Procedures involving the removal of an HCT/P from a patient and the implantation of that same HCT/P back into the same patient during the same surgical procedure are not subject to FDA regulation; 21 CFR 1271.15(b).
Regenexx is proud of its history of regulatory compliance and is deeply familiar with the regulatory environment in which it operates. If you have any questions about our regulatory compliance, please feel free to ask and we will be happy to speak with you in further detail.